Meet the man making synthetic psychedelics – for research & beyond
Psychedelics – for research – need to be made somewhere. Peter van der Heyden – CSO of Psygen – told me about the process.
Psychedelics – for research – need to be made somewhere. Peter van der Heyden – CSO of Psygen – told me about the process.
Looking inside the brain may help us understand how and why psychedelics work.
Update on the progress of Blossom – psychedelic insights – of May 2022 | Another report finished & introduction of daily blogs
Since the turn of the century, there have only been eight psychedelic clinical trials investigating anxiety. Of these studies, most have looked at end-of-life anxiety. This leaves a whole field of psychedelics for the betterment of mental health open.
We had the chance to speak with Dr Grace Blest-Hopley at Plant Medicine Week to discuss the work she and her colleagues are doing at Heroic Hearts, how psychedelics are helping veterans with traumatic brain injury, and more.
Veterans face unique mental health challenges due to their service – rates of depression, anxiety and PTSD are much higher among this group when compared to the general population.
Three months after a high dose of psilocybin, 40% of participants with anorexia saw improvements.
The research group UNITy – Understanding Neuroplasticity Induced by Tryptamines – wants to change that. The crowdfunded study – using DMT – will be the most extensive fMRI study with psychedelics to date.
Over April, we continued to learn more about psychedelic medicine. Let’s take a quick look at some of the exciting articles released into the wild in April.
The time is ripe to develop female-focused psychedelic medicine.